Molecular Infectious Disease

Embrace the power of advanced diagnostics with PrecisionUTI. This state-of-the-art diagnostic tool leverages PCR technology to screen for 29 unique UTI-related targets, including a wide range of pathogens from Acinetobacter baumannii to Pseudomonas aeruginosa, along with certain viruses and Candida species. Unlike traditional culture methods, PCR technology amplifies traces of DNA or RNA specific to the pathogens, allowing for faster and more accurate identification. Furthermore, PrecisionUTI™ goes beyond merely identifying pathogens, it also detects a variety of antibiotic resistance genes, allowing for the design of more effective, personalized treatment plans. By providing rapid, precise diagnoses, PrecisionUTI ensures optimal patient care and empowers healthcare providers with the confidence to make informed treatment decisions.

Embrace the next-level care with PrecisionRPP™, our proprietary respiratory pathogen profiling test. From one single sample, we now provide detailed analysis for 32 different respiratory targets, encompassing a broad spectrum of viral and bacterial pathogens. With conditions ranging from Corona HKU1, Corona 229E, Influenza A/B, Human Parainfluenza strains, Klebsiella pneumoniae, and MRSA to more specialized targets such as Human Bocavirus, we offer comprehensive coverage to ensure precise diagnosis.

Welcome to a new era of sexually transmitted infection (STI) diagnostics with PrecisionSTI™. Our cutting-edge test is designed to accurately detect and diagnose a wide range of STIs within a swift 24-hour turnaround time. It screens for nine significant targets, including Chlamydia trachomatis, Neisseria gonorrhaeae, Treponema pallidum, Trichomonas Vaginalis, Mycoplasma genitalium, and important viruses such as HIV 1/2, Hepatitis B, Hepatitis C, and HIV Ag/Ab. By delivering rapid, accurate results, PrecisionSTI™ is a powerful tool for healthcare providers, enabling timely and targeted treatment interventions that are key to patient health and wellbeing

We offer real-time RT-PCR assay to detect severe acute respiratory syndrome coronavirus (SARS-CoV-2) that can be combined with our respiratory pathogen panel because of the high co-infection rates of COVID-19 patients.